Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

MLA

Lopes, Renato D., et al. “Efficacy and Safety of Apixaban Compared with Warfarin According to Patient Risk of Stroke and of Bleeding in Atrial Fibrillation: A Secondary Analysis of a Randomised Controlled Trial.” Lancet (London, England), vol. 380, no. 9855, Nov. 2012, pp. 1749–58. EBSCOhost, https://doi.org/10.1016/S0140-6736(12)60986-6.

APA

Lopes, R. D., Al-Khatib, S. M., Wallentin, L., Yang, H., Ansell, J., Bahit, M. C., De Caterina, R., Dorian, P., Easton, J. D., Erol, C., Ezekowitz, J. A., Gersh, B. J., Granger, C. B., Hohnloser, S. H., Horowitz, J., Hylek, E. M., McMurray, J. J. V., Mohan, P., Vinereanu, D., & Alexander, J. H. (2012). Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet (London, England), 380(9855), 1749–1758. https://doi.org/10.1016/S0140-6736(12)60986-6

Chicago

Lopes, Renato D, Sana M Al-Khatib, Lars Wallentin, Hongqiu Yang, Jack Ansell, M Cecilia Bahit, Raffaele De Caterina, et al. 2012. “Efficacy and Safety of Apixaban Compared with Warfarin According to Patient Risk of Stroke and of Bleeding in Atrial Fibrillation: A Secondary Analysis of a Randomised Controlled Trial.” Lancet (London, England) 380 (9855): 1749–58. doi:10.1016/S0140-6736(12)60986-6.